Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Bishop Philippe C — Atreca, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Bishop Philippe C

Bishop Philippe C

Chief Medical Officer at Atreca, Inc. · on record since Jan 11, 2023

Insider trading activity of Bishop Philippe C

Transactions on record: 1; since Jan 11, 2023

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jan 11, 2023

Figures computed from official regulatory filings — methodology.

Companies where Bishop Philippe C has traded

Atreca, Inc.1 tx · Jan 11, 2023

Track record of Bishop Philippe C

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Bishop Philippe C

Co-insiders of Bishop Philippe C

ATWOOD BRIAN GAtreca, Inc.
Baker Bros. Advisors (GP) LLCAtreca, Inc.
BAKER BROS. ADVISORS LPAtreca, Inc.
BAKER FELIXAtreca, Inc.
BAKER JULIANAtreca, Inc.
BALL KRISTINE MAtreca, Inc.
BERGER FRANKLIN MAtreca, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Bill & Melinda Gates FoundationAtreca, Inc.

Brady Stephen RAtreca, Inc.

Cavet GuyAtreca, Inc.

Courtney PhillipsAtreca, Inc.

CROSS HERBAtreca, Inc.

Decker Lisa LynnAtreca, Inc.

Gould Stephen EAtreca, Inc.

Greenberg Norman MichaelAtreca, Inc.

Green JeremyAtreca, Inc.

Hadley Harbor Master Investors (Cayman) II L.P.Atreca, Inc.

Lacey David L.Atreca, Inc.

Ma StaceyAtreca, Inc.

Orwin John AAtreca, Inc.

Redmile Group, LLCAtreca, Inc.

Robinson William HewittAtreca, Inc.

Rolfe LindseyAtreca, Inc.

Ruiz Roger RichardAtreca, Inc.

SERAFINI TITOAtreca, Inc.

STEINMAN LAWRENCEAtreca, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Atreca, Inc.	Jan 11, 2023	AwardD	350,000	0.00 USD	$0	SEC